Guide to buying Johnson-and-Johnson stock in Canada

Johnson-and-Johnson is a drug manufacturers - general business based in the US. Johnson-and-Johnson stocks (JNJ) are listed on the NYSE, and all prices are listed in US Dollars.

Johnson-and-Johnson employs 138,100 staff and has a trailing 12-month revenue of around $92.1 billion.

Keep reading to see up-to-date Johnson-and-Johnson stock price and performance data, along with a step-by-step guide for how to buy Johnson-and-Johnson stock in Canada.

Johnson-and-Johnson (JNJ) stock summary

Company stock name	Johnson & Johnson
Stock ticker symbol	JNJ
Exchange	NYSE
Open	$207.00
High	$207.46
Low	$204.63
Close	$206.92
Adjusted closing	$206.92
Volume The number of stocks traded during the day	5,638,279
52-week stock price range	$136.50 – $207.81
Where to buy Johnson-and-Johnson stock	Buy on CIBC Investor's Edge

The values in this table are accurate as of the market close on November 27, 2025, and all amounts are in USD.

Can I buy Johnson-and-Johnson stock in Canada?

Yes, you can buy Johnson-and-Johnson stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NYSE exchange. Platforms like Interactive Brokers will allow you to directly buy Johnson-and-Johnson stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy Johnson-and-Johnson stock

Johnson-and-Johnson stock chart (NYSE: JNJ)

This chart tracks Johnson-and-Johnson stock price performance over time.

Johnson-and-Johnson stock price

Johnson-and-Johnson's stock price at the last available market close was $206.92 (as of November 27, 2025). For comparison, a full 30 days ago it was $188.87.

Is Johnson-and-Johnson stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for Johnson-and-Johnson stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy Johnson-and-Johnson stock on the TSX?

No, you cannot buy Johnson-and-Johnson stock on the TSX because Johnson-and-Johnson stock is not listed on the TSX. Instead, Johnson-and-Johnson stock is listed on the NYSE under the symbol "JNJ."

That said, if you're wondering how to invest in Johnson-and-Johnson stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Interactive Brokers.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Johnson-and-Johnson stock dividends

Johnson-and-Johnson dividend payout ratio: 42.3% of net profits

Recently Johnson-and-Johnson has paid out, on average, around 42.3% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.53% of the current stock value.

This means that, over a year, based on recent payouts (which are sadly no guarantee of future payouts), Johnson-and-Johnson shareholders could enjoy a 2.53% return on their shares in the form of dividend payments. In Johnson-and-Johnson's case, that would currently equate to about $5.08 per share.

While Johnson-and-Johnson's payout ratio might seem fairly standard, it's worth remembering that Johnson-and-Johnson may be investing much of the rest of its net profits in future growth.

Johnson-and-Johnson's next dividend payout is expected around December 9, 2025. To benefit, you'll need to buy Johnson-and-Johnson stocks before November 25, 2025 (the "ex-dividend date").

Johnson-and-Johnson stock performance metrics

Here are some common key metrics for Johnson-and-Johnson stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• Johnson-and-Johnson's P/E ratio

  Johnson-and-Johnson's current share price divided by its per-share earnings (EPS) over the past 12 months gives a trailing price/earnings (P/E) ratio of roughly 19x. In other words, Johnson-and-Johnson shares trade at around 19 times recent earnings.

  That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

• Johnson-and-Johnson's PEG ratio

  Johnson-and-Johnson's price/earnings-to-growth (PEG) ratio is calculated by dividing its P/E ratio by its earnings growth, which comes out to about 1.0784. A lower ratio can suggest a stock offers better value, while a higher ratio may suggest worse value.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in Johnson-and-Johnson's expected earnings growth. By accounting for growth, investors can use the PEG ratio to compare the valuations of multiple high-growth companies.

• Johnson-and-Johnson's EBITDA

  Johnson-and-Johnson's EBITDA (earnings before interest, taxes, depreciation and amortization) is $31.9 billion. EBITDA is a measure of a company's overall financial performance and is often used as a proxy for a company's profitability.

Has Johnson-and-Johnson stock ever split?

Johnson-and-Johnson's stocks were split on a 2:1 basis on June 12, 2001. So, if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Johnson-and-Johnson stocks, just the quantity.

However, indirectly, the new 50% lower stock price could have impacted the market appetite for Johnson-and-Johnson stocks, which in turn could have impacted Johnson-and-Johnson's stock price.

How volatile is Johnson-and-Johnson stock?

Over the last 12 months, Johnson-and-Johnson's stocks price has ranged from $136.50 to as high as $207.81. Johnson-and-Johnson's beta measurement of stock volatility is 0.36. For comparison, the market () average beta is 1. This would suggest that Johnson-and-Johnson's stocks are less volatile than average (on this exchange).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of Johnson-and-Johnson's beta stock volatility rating.

Johnson & Johnson company and revenue performance

Market Capitalization The total market value of Johnson-and-Johnson's outstanding shares	$494.7 billion
Gross profit (TTM)	$63 billion
Operating margin (TTM)	30.20%
Profit margin	27.26%
Revenue (TTM)	$92.1 billion
Return on assets (TTM)	8.26%
Return on equity (TTM)	33.62%
Earnings per share (TTM)	$10.36
50-day moving stock price average The average share price over the last 50 days	$191.29
200-day moving stock price average The average share price over the last 200 days	$169.34

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on December 3, 2025.

Johnson-and-Johnson company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.

The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke.

This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics.

The company was founded in 1886 and is based in New Brunswick, New Jersey.

• Common company-related questions about Johnson-and-Johnson

  What percentage of Johnson-and-Johnson is owned by insiders or institutions?
  Currently 0.058% of Johnson-and-Johnson stocks are held by insiders and 74.967% by institutions.

  How many people work for Johnson-and-Johnson?
  Latest data suggests 138,100 work at Johnson-and-Johnson.

  When does the fiscal year end for Johnson-and-Johnson?
  Johnson-and-Johnson's fiscal year ends in December.

  Where is Johnson-and-Johnson based?
  Johnson-and-Johnson's address is: One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933

  What is Johnson-and-Johnson's ISIN number?
  Johnson-and-Johnson's international securities identification number is: US4781601046

  What is Johnson-and-Johnson's CUSIP number?
  Johnson-and-Johnson's Committee on Uniform Securities Identification Procedures number is: 478160104

Compare trading platforms to buy Johnson-and-Johnson stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from Johnson-and-Johnson stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Johnson-and-Johnson stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about Johnson-and-Johnson stock

• Can I buy Johnson-and-Johnson stock directly as a Canadian investor?

  Yes, Canadian investors can buy Johnson-and-Johnson stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying Johnson-and-Johnson stock in our table here.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of Johnson-and-Johnson stock?

  Yes, it may be possible to buy fractional shares of Johnson-and-Johnson stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in Johnson-and-Johnson stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  3 of 3 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted Finder Score 8.8 Great Interactive Brokers	Finder Score 8.8 Great	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint	min $1.00, max 0.5%	$0	Go to site More info Compare product selection Compare	loading
  Finder Score 7.4 Great Moomoo Financial Canada	Finder Score 7.4 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, FHSA	$1.49/stock	$0	Get up to $4,600 in trading perks. T&Cs apply.	Go to site More info Compare product selection Compare	loading
  Finder Score 9.1 Excellent Questrade	Finder Score 9.1 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA	$0	$0	Get free contracts, no commissions and a 30 day free trial of Questrade Plus. Use offer code FREEOPTIONS. T&Cs apply.	Go to site More info Compare product selection Compare	loading

  loading

  Load More

  Showing 3 of 3 results

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.